Øystein Åmellem

Director, Cell Biology • Thermo Fisher Scientific Inc

Øystein’s professional experience is derived from different leadership positions in R&D, Product Management and Business for over 22 years in Thermo Fisher Scientific, he is responsible for development and commercialization of products and services for the cell therapy market. His scientific training is in the field of molecular cell biology and he received a PhD from the University of Oslo. Øystein’s academic career focused on the study of physiological & molecular mechanisms of tumor cell growth and the development of novel therapies for the treatment of solid tumors in collaboration with Norsk Hydro

Also Speaking

Karen Walker

Chief Technical Officer • Kyverna Therapeutics

Jean Stanton

Director, Global Cell Collection • Janssen

Åsa Hagner Mcwhirter

Principal Scientist • Cytiva

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.